Yes OCYC - this does look exciting but I find it perplexing that the trials are being done in USA and India - why isn’t a trial being conducted here. -
- Better control of how test is conducted
- Can instantly modify Algorithm if needed
- Have more control of the hospitals used and the patients tested
- Would be cheaper to run
- Results faster and Prof here to oversee
- Importantly know what to expect before trialling In other countries - a bad result will be hard to come back from.
- I feel we are going about this the wrong way - we don’t have anyone in these countries to oversee and look what happened to our FDA trials - I hope I am wrong but TK should explain his reasononing. AIMO
- Forums
- ASX - By Stock
- RAP
- Ann: ResAppDx receives regulatory approval in Indonesia
Ann: ResAppDx receives regulatory approval in Indonesia, page-24
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online